{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:10:26Z","timestamp":1785355826815,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council (GB)","doi-asserted-by":"publisher","award":["PhD studentship"],"award-info":[{"award-number":["PhD studentship"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation (US)","doi-asserted-by":"publisher","award":["A-3450"],"award-info":[{"award-number":["A-3450"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12864-015-2251-4","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T11:46:23Z","timestamp":1450698383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Similar striatal gene expression profiles in the striatum of the YAC128 and HdhQ150 mouse models of Huntington\u2019s disease are not reflected in mutant Huntingtin inclusion prevalence"],"prefix":"10.1186","volume":"16","author":[{"given":"Zubeyde","family":"Bayram-Weston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Elliston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nari","family":"Janghra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma V.","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Holmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Dunnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3007-4612","authenticated-orcid":false,"given":"Lesley","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,21]]},"reference":[{"key":"2251_CR1","doi-asserted-by":"crossref","unstructured":"The Huntington's disease collaborative research group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971\u2013983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"2251_CR2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","volume":"69","author":"ZR Crook","year":"2011","unstructured":"Crook ZR, Housman D. Huntington\u2019s disease: can mice lead the way to treatment? Neuron. 2011;69:423\u201335.","journal-title":"Neuron"},{"key":"2251_CR3","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andre VM, Wilburn B, Lu XH, et al. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci. 2008;28:6182\u201395.","journal-title":"J Neurosci"},{"key":"2251_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, et al. Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum Mol Genet. 2001;10:137\u201344.","journal-title":"Hum Mol Genet"},{"key":"2251_CR5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87:493\u2013506.","journal-title":"Cell"},{"key":"2251_CR6","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1523\/JNEUROSCI.22-18-08266.2002","volume":"22","author":"LB Menalled","year":"2002","unstructured":"Menalled LB, Sison JD, Wu Y, Olivieri M, Li XJ, Li H, et al. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. J Neurosci. 2002;22:8266\u201376.","journal-title":"J Neurosci"},{"key":"2251_CR7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"VC Wheeler","year":"1999","unstructured":"Wheeler VC, Auerbach W, White JK, Srinidhi J, Auerbach A, Ryan A, et al. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum Mol Genet. 1999;8:115\u201322.","journal-title":"Hum Mol Genet"},{"key":"2251_CR8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.brainresbull.2011.07.021","volume":"88","author":"KR Bowles","year":"2012","unstructured":"Bowles KR, Brooks SP, Dunnett SB, Jones L. Gene Expression and Behaviour in Mouse Models of Huntington's Disease. Brain Res Bull. 2012;88:276\u201384.","journal-title":"Brain Res Bull"},{"key":"2251_CR9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1460-9568.2007.05307.x","volume":"25","author":"RC Trueman","year":"2007","unstructured":"Trueman RC, Brooks SP, Jones L, Dunnett SB. The operant serial implicit learning task reveals early onset motor learning deficits in the Hdh knock-in mouse model of Huntington's disease. Eur J Neurosci. 2007;25:551\u20138.","journal-title":"Eur J Neurosci"},{"key":"2251_CR10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.brainresbull.2006.02.011","volume":"69","author":"SP Brooks","year":"2006","unstructured":"Brooks SP, Betteridge H, Trueman RC, Jones L, Dunnett SB. Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease. Brain Res Bull. 2006;69:452\u20137.","journal-title":"Brain Res Bull"},{"key":"2251_CR11","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci. 1999;19:3248\u201357.","journal-title":"J Neurosci"},{"key":"2251_CR12","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","volume":"19","author":"LA Lione","year":"1999","unstructured":"Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, Dunnett SB. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci. 1999;19:10428\u201337.","journal-title":"J Neurosci"},{"key":"2251_CR13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet. 2003;12:1555\u201367.","journal-title":"Hum Mol Genet"},{"key":"2251_CR14","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","volume":"25","author":"JM Raamsdonk Van","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Slow EJ, Hossain SM, Leavitt BR, Hayden MR. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J Neurosci. 2005;25:4169\u201380.","journal-title":"J Neurosci"},{"key":"2251_CR15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainresbull.2010.05.003","volume":"88","author":"S Brooks","year":"2012","unstructured":"Brooks S, Higgs G, Jones L, Dunnett SB. Longitudinal analysis of the behavioural phenotype in Hdh(Q92) Huntington's disease knock-in mice. Brain Res Bull. 2012;88:148\u201355.","journal-title":"Brain Res Bull"},{"key":"2251_CR16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainresbull.2010.05.004","volume":"88","author":"S Brooks","year":"2012","unstructured":"Brooks S, Higgs G, Jones L, Dunnett SB. Longitudinal analysis of the behavioural phenotype in Hdh((CAG)150) Huntington's disease knock-in mice. Brain Res Bull. 2012;88:182\u20138.","journal-title":"Brain Res Bull"},{"key":"2251_CR17","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","volume":"16","author":"A Kuhn","year":"2007","unstructured":"Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T, Kooperberg C, et al. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet. 2007;16:1845\u201361.","journal-title":"Hum Mol Genet"},{"key":"2251_CR18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, et al. Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet. 2006;15:965\u201377.","journal-title":"Hum Mol Genet"},{"key":"2251_CR19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1460-9568.2005.03895.x","volume":"21","author":"AJ Morton","year":"2005","unstructured":"Morton AJ, Hunt MJ, Hodges AK, Lewis PD, Redfern AJ, Dunnett SB, et al. A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease. European J Neuroscience. 2005;21:855\u201370.","journal-title":"European J Neuroscience"},{"key":"2251_CR20","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","volume":"100","author":"E Hockly","year":"2003","unstructured":"Hockly E, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E, et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A. 2003;100:2041\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2251_CR21","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","volume":"23","author":"RJ Ferrante","year":"2003","unstructured":"Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, et al. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci. 2003;23:9418\u201327.","journal-title":"J Neurosci"},{"key":"2251_CR22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","volume":"280","author":"G Gardian","year":"2005","unstructured":"Gardian G, Browne SE, Choi DK, Klivenyi P, Gregorio J, Kubilus JK, et al. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem. 2005;280:556\u201363.","journal-title":"J Biol Chem"},{"key":"2251_CR23","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","volume":"105","author":"EA Thomas","year":"2008","unstructured":"Thomas EA, Coppola G, Desplats PA, Tang B, Soragni E, Burnett R, et al. The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice. Proc Natl Acad Sci U S A. 2008;105:15564\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2251_CR24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainresbull.2011.05.010","volume":"88","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Janghra N, Higgs GV, Bayram-Weston Z, Heuer A, Jones L, et al. Selective cognitive impairment in the YAC128 Huntington's disease mouse. Brain Res Bull. 2012;88:121\u20139.","journal-title":"Brain Res Bull"},{"key":"2251_CR25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainresbull.2011.06.008","volume":"88","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Jones L, Dunnett SB. Longitudinal analyses of operant performance on the serial implicit learning task (SILT) in the YAC128 Huntington's disease mouse line. Brain Res Bull. 2012;88:130\u20136.","journal-title":"Brain Res Bull"},{"key":"2251_CR26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","volume":"132","author":"MA Pouladi","year":"2009","unstructured":"Pouladi MA, Graham RK, Karasinska JM, Xie Y, Santos RD, Petersen A, et al. Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain. 2009;132:919\u201332.","journal-title":"Brain"},{"key":"2251_CR27","doi-asserted-by":"crossref","unstructured":"Brooks S, Higgs G, Janghra N, Jones L, Dunnett SB: Longitudinal analysis of the behavioural phenotype in YAC128 (C57BL\/6 J) Huntington\u2019s disease transgenic mice. Brain Res Bull in press.","DOI":"10.1016\/j.brainresbull.2010.05.005"},{"key":"2251_CR28","doi-asserted-by":"crossref","unstructured":"Brooks SP, Janghra N, Higgs GV, Bayram-Weston Z, Heuer A, Jones L, Dunnett SB: Selective cognitive impairment in the YAC128 Huntington's disease mouse. Brain Res Bull in press.","DOI":"10.1016\/j.brainresbull.2011.05.010"},{"key":"2251_CR29","doi-asserted-by":"crossref","unstructured":"Brooks SP, Jones L, Dunnett SB: Longitudinal analyses of operant performance on the serial implicit learning task (SILT) in the YAC128 Huntington's disease mouse line. Brain Res Bull in press.","DOI":"10.1016\/j.brainresbull.2011.06.008"},{"key":"2251_CR30","unstructured":"Bayram-Weston Z, Jones L, Dunnett SB, Brooks SP: Light and electron microscopic characterization of the evolution of cellular pathology in YAC128 Huntington's disease transgenic mice. Brain Res Bull in press."},{"key":"2251_CR31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"2251_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W Huang da","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1\u201313.","journal-title":"Nucleic Acids Res"},{"key":"2251_CR33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1601-183X.2007.00350.x","volume":"7","author":"A Hodges","year":"2008","unstructured":"Hodges A, Hughes G, Brooks S, Elliston L, Holmans P, Dunnett SB, et al. Brain gene expression correlates with changes in behavior in the R6\/1 mouse model of Huntington's disease. Genes Brain Behav. 2008;7:288\u201399.","journal-title":"Genes Brain Behav"},{"key":"2251_CR34","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","volume":"27","author":"AD Strand","year":"2007","unstructured":"Strand AD, Baquet ZC, Aragaki AK, Holmans P, Yang L, Cleren C, et al. Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci. 2007;27:11758\u201368.","journal-title":"J Neurosci"},{"key":"2251_CR35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.brainresbull.2011.10.001","volume":"88","author":"P Giles","year":"2012","unstructured":"Giles P, Elliston L, Higgs GV, Brooks SP, Dunnett SB, Jones L. Gene expression changes over time and correlated with behaviour in the HdhQ150 mouse model of HD. Brain Res Bull. 2012;88:199\u2013209.","journal-title":"Brain Res Bull"},{"key":"2251_CR36","doi-asserted-by":"crossref","unstructured":"Brooks S, Higgs G, Jones L, Dunnett SB: Longitudinal analysis of the behavioural phenotype in Hdh((CAG)150) Huntington's disease knock-in mice. Brain Res Bull in press.","DOI":"10.1016\/j.brainresbull.2010.05.004"},{"key":"2251_CR37","doi-asserted-by":"crossref","unstructured":"Bayram-Weston Z, Torres EM, Jones L, Dunnett SB, Brooks SP: Light and electron microscopic characterization of the evolution of cellular pathology in the Hdh((CAG)150) Huntington's disease knock-in mouse. Brain Res Bull in press.","DOI":"10.1016\/j.brainresbull.2011.03.014"},{"key":"2251_CR38","volume":"7","author":"B Gong","year":"2012","unstructured":"Gong B, Kielar C, Morton AJ. Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutation. PLoS One. 2012;7, e41450.","journal-title":"PLoS One"},{"key":"2251_CR39","unstructured":"Giles P, Elliston L, Higgs GV, Brooks SP, Dunnett SB, Jones L: Gene expression changes over time and correlated with behaviour in the HdhQ150 mouse model of HD. Brain Res Bull in press."},{"key":"2251_CR40","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0140-6736(06)68930-7","volume":"367","author":"J Collinge","year":"2006","unstructured":"Collinge J, Whitfield J, McKintosh E, Beck J, Mead S, Thomas DJ, et al. Kuru in the 21st century--an acquired human prion disease with very long incubation periods. Lancet. 2006;367:2068\u201374.","journal-title":"Lancet"},{"key":"2251_CR41","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1098\/rstb.2008.0087","volume":"363","author":"S Mead","year":"2008","unstructured":"Mead S, Whitfield J, Poulter M, Shah P, Uphill J, Beck J, et al. Genetic susceptibility, evolution and the kuru epidemic. Philos Trans R Soc Lond B Biol Sci. 2008;363:3741\u20136.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2251_CR42","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1523\/JNEUROSCI.0146-10.2010","volume":"30","author":"J Miller","year":"2010","unstructured":"Miller J, Arrasate M, Shaby BA, Mitra S, Masliah E, Finkbeiner S. Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis. J Neurosci. 2010;30:10541\u201350.","journal-title":"J Neurosci"},{"key":"2251_CR43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004;431:805\u201310.","journal-title":"Nature"},{"key":"2251_CR44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ng1297-404","volume":"17","author":"JK White","year":"1997","unstructured":"White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, et al. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat Genet. 1997;17:404\u201310.","journal-title":"Nat Genet"},{"key":"2251_CR45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.nbd.2005.08.007","volume":"21","author":"RK Graham","year":"2006","unstructured":"Graham RK, Slow EJ, Deng Y, Bissada N, Lu G, Pearson J, et al. Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models. Neurobiol Dis. 2006;21:444\u201355.","journal-title":"Neurobiol Dis"},{"key":"2251_CR46","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","volume":"15","author":"JM Raamsdonk Van","year":"2006","unstructured":"Van Raamsdonk JM, Gibson WT, Pearson J, Murphy Z, Lu G, Leavitt BR, et al. Body weight is modulated by levels of full-length huntingtin. Hum Mol Genet. 2006;15:1513\u201323.","journal-title":"Hum Mol Genet"},{"key":"2251_CR47","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/hmg\/ddr195","volume":"20","author":"JC Jacobsen","year":"2011","unstructured":"Jacobsen JC, Gregory GC, Woda JM, Thompson MN, Coser KR, Murthy V, et al. HD CAG-correlated gene expression changes support a simple dominant gain of function. Hum Mol Genet. 2011;20:2846\u201360.","journal-title":"Hum Mol Genet"},{"key":"2251_CR48","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/503820","volume":"78","author":"FJ McMahon","year":"2006","unstructured":"McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet. 2006;78:804\u201314.","journal-title":"Am J Hum Genet"},{"key":"2251_CR49","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s00259-005-1772-5","volume":"32","author":"K Peremans","year":"2005","unstructured":"Peremans K, Audenaert K, Hoybergs Y, Otte A, Goethals I, Gielen I, et al. The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measured with 123I-5-I-R91150 SPECT. Eur J Nucl Med Mol Imaging. 2005;32:708\u201316.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2251_CR50","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-1781(96)02935-6","volume":"63","author":"DF Papolos","year":"1996","unstructured":"Papolos DF, Yu YM, Rosenbaum E, Lachman HM. Modulation of learned helplessness by 5-hydroxytryptamine2A receptor antisense oligodeoxynucleotides. Psychiatry Res. 1996;63:197\u2013203.","journal-title":"Psychiatry Res"},{"key":"2251_CR51","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","volume":"62","author":"K Duff","year":"2007","unstructured":"Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC. Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol Psychiatry. 2007;62:1341\u20136.","journal-title":"Biol Psychiatry"},{"key":"2251_CR52","volume":"3","author":"AL Vaccarino","year":"2011","unstructured":"Vaccarino AL, Sills T, Anderson KE, Bachoud-Levi AC, Borowsky B, Craufurd D, et al. Assessment of depression, anxiety and apathy in prodromal and early huntington disease. PLoS Curr. 2011;3, RRN1242.","journal-title":"PLoS Curr"},{"key":"2251_CR53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ejhg.2008.146","volume":"17","author":"M Gargiulo","year":"2009","unstructured":"Gargiulo M, Lejeune S, Tanguy ML, Lahlou-Laforet K, Faudet A, Cohen D, et al. Long-term outcome of presymptomatic testing in Huntington disease. Eur J Hum Genet. 2009;17:165\u201371.","journal-title":"Eur J Hum Genet"},{"key":"2251_CR54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier L, Cope L, Bolstad BM, Irizarry RA. affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20:307\u201315.","journal-title":"Bioinformatics"},{"issue":"Iss. 1","key":"2251_CR55","first-page":"Article 3","volume":"Vol. 3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology. 2004;Vol. 3(Iss. 1):Article 3.","journal-title":"Statistical Applications in Genetics and Molecular Biology"},{"key":"2251_CR56","doi-asserted-by":"crossref","first-page":"9923","DOI":"10.1073\/pnas.1002757107","volume":"107","author":"B Zhou","year":"2010","unstructured":"Zhou B, Xu W, Herndon D, Tompkins R, Davis R, Xiao W, et al. Analysis of factorial time-course microarrays with application to a clinical study of burn injury. Proc Natl Acad Sci U S A. 2010;107:9923\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2251_CR57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate:A practical and powerful appraoch to multiple testing. J R Statist Soc B. 1995;57:289\u2013300.","journal-title":"J R Statist Soc B"},{"key":"2251_CR58","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2251_CR59","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"2251_CR60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013984","volume":"5","author":"D Merico","year":"2010","unstructured":"Merico D, Isserlin R, Stueker O, Emili A, Bader GD. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One. 2010;5, e13984.","journal-title":"PLoS One"},{"key":"2251_CR61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainresbull.2011.05.005","volume":"88","author":"Z Bayram-Weston","year":"2012","unstructured":"Bayram-Weston Z, Jones L, Dunnett SB, Brooks SP. Light and electron microscopic characterization of the evolution of cellular pathology in YAC128 Huntington's disease transgenic mice. Brain Res Bull. 2012;88:137\u201347.","journal-title":"Brain Res Bull"},{"key":"2251_CR62","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1073\/pnas.0437967100","volume":"100","author":"S Holbert","year":"2003","unstructured":"Holbert S, Dedeoglu A, Humbert S, Saudou F, Ferrante RJ, Neri C. Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease. Proc Natl Acad Sci U S A. 2003;100:2712\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2251_CR63","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","volume":"285","author":"C Landles","year":"2010","unstructured":"Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H, Finkbeiner S, et al. Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem. 2010;285:8808\u201323.","journal-title":"J Biol Chem"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-015-2251-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T07:23:50Z","timestamp":1718263430000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2164\/16\/1079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2251"],"URL":"https:\/\/doi.org\/10.1186\/s12864-015-2251-4","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"1079"}}